| Business Name: |
Stephen G Geiger Md |
| Contact Person: |
Michael Errico |
| Address: |
585 Plandome Road, Manhasset, New York 11030 |
| Phone Number: |
(516) 627-1525 |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Founding Year: |
2010 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2C (Business to Consumer) |
| Business Category: |
Doctors |
| SIC Code: |
8011 |
| NAICS Code: |
621111 |
| Share This Business: |
|
| Related Businesses: |
NY Specialty Physicians - Manhasset, NY 11030
Griffin Kimberly M MD - Manhasset, NY 11030
Eichen Aimee L MD - Manhasset, NY 11030
Feinberg Joseph MD - Manhasset, NY 11030
Katz Jack MD - Manhasset, NY 11030
Friedman David MD - Manhasset, NY 11030
Efthimiou Elizabeth M MD - Manhasset, NY 11030
Cohen Alan J MD - Manhasset, NY 11030
Frid Elena MD - Manhasset, NY 11030
Donatelli Jr Anthony M MD - Manhasset, NY 11030
Coopersmith Helise MD - Manhasset, NY 11030
Boyar Vitaliya M MD - Manhasset, NY 11030
Cirilli Angela R MD - Manhasset, NY 11030
Fish Bilha MD - Manhasset, NY 11030
Forte Richard S MD - Manhasset, NY 11030
Altman Erik J MD - Manhasset, NY 11030
Bloom Karen MD - Manhasset, NY 11030
Garibaldi Daniel MD - Manhasset, NY 11030
Frankenthaler Michael L MD - Manhasset, NY 11030
Mieres Jennifer MD - Manhasset, NY 11030
|
The company Stephen G Geiger Md provides B2C services in the form of Doctors from its single location in New York.
1 to 4 employees work for Stephen G Geiger Md, and the business now earns $100.000 to $499.999 per annum.
Stephen G Geiger Md was launched in 2010 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 .
To contact Stephen G Geiger Md, please call Michael Errico with the phone number (516) 627-1525 or visit its single location at 585 Plandome Road in Manhasset, New York 11030.
The location of the single location can also be found using the coordinates 40.800167,-73.701769.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.